Muscular dystrophies, the cytoskeleton and cell adhesion

BioEssays

Volumn 24, Issue 6, 2002, Pages 542-552

  Spence, Heather J ^a   Chen, Yun Ju ^a   Winder, Steven J ^a,b  

^a Institute of Biological and Life Sciences   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DYSTROPHIN; GLYCOPROTEIN; INTEGRIN;

ANIMAL; BIOLOGICAL MODEL; CELL ADHESION; CYTOSKELETON; GENETICS; INTERMEDIATE FILAMENT; METABOLISM; MOUSE; MOUSE MUTANT; MUSCULAR DYSTROPHY; MUTATION; PATHOLOGY; PHENOTYPE; REVIEW; SKELETAL MUSCLE;

ANIMALS; CELL ADHESION; CYTOSKELETON; DYSTROPHIN; GLYCOPROTEINS; INTEGRINS; INTERMEDIATE FILAMENTS; MICE; MICE, KNOCKOUT; MODELS, BIOLOGICAL; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES; MUTATION; PHENOTYPE;

EID: 0035983270     PISSN: 02659247     EISSN: None     Source Type: Journal    
DOI: 10.1002/bies.10098     Document Type: Review

References (98)

1. A vinculin-containing cortical lattice in skeletal muscle: Transverse lattice elements ('costameres') mark the sites of attachment between myofibrils and sarcolemma
2. Supramolecular organization of the subsarcolemmal cytoskeleton of adult skeletal muscle fibers. A review
3. Complete cloning of the Duchenne muscular-dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals
4. The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein
5. Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle
6. Membrane organisation of the dystrophin-membrane complex
7. Dystrophin-glycoprotein complex is highly enriched in isolated skeletal muscle sarcolemma
8. Three muscular dystrophies: Loss of cytoskeleton-extracellular matrix linkage
9. Dystrophin and utrophin: The missing links!
10. The complexities of dystroglycan
11. Dystrophin-associated proteins are greatly reduced in skeletal-muscle from Mdx mice
12. Dp71 can restore the dystrophin-associated glycoprotein complex in muscle but fails to prevent dystrophy
13. Exogenous Dp71 restores the levels of dystrophin-associated proteins but does not alleviate muscle damage in mdx mice
14. Transgenic mdx mice expressing dystrophin with a deletion in the actin-binding domain display a "mild Becker" phenotype
15. Exploring the molecular basis for variability among patients with Becker muscular-dystrophy - Dystrophin gene and protein studies
16. Dystrophin-glycoprotein complex is monomeric and stabilizes actin filaments in vitro through a lateral association
17. A new model for the interaction of dystrophin with F-actin
18. The membrane-cytoskeleton interface: The role of dystrophin and utrophin
19. Utrophin lacks the rod domain actin-binding activity of dystrophin
20. Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene
21. The dystrophin complex forms a mechanically strong link between the sarcolemma and costameric actin
22. Synemin may function to directly link muscle cell intermediate filaments to both myofibrillar Z-lines and costameres
23. Dystrophin colocalises with β-spectrin in distinct subsarcolemmal domains in mammalian skeletal muscle
24. A role for dystroglycan in basement membrane assembly
25. Dystroglycan is essential for early embryonic development: Disruption of Reichert's membrane in Dag1-null mice
26. Chimeric mice deficient in dystroglycans develop muscular dystrophy and have disrupted myoneural synapses
27. Dissociation of the complex of dystrophin and its associated proteins into several groups by n-octyl β-D-glucoside
28. Assembly of the sarcoglycan complex. Insights for muscular dystrophy
29. Role for alpha-dystrobrevin in the pathogenesis of dystrophin-dependent muscular dystrophies
30. Syntrophin binds to an alternatively spliced exon of dystrophin
31. Coiled-coil regions in the carboxy terminal domains of dystrophin and related proteins: Potentials for protein-protein interactions
32. Isoform diversity of dystrobrevin, the murine 87-kDa postsynaptic protein
33. Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy
34. Knocking signalling out of the dystrophin complex
35. Targeted disruption of the neuronal nitric oxide synthase gene
36. α1-Syntrophin gene disruption results in the absence of neuronal-type nitric-oxide synthase at the sarcolemma but does not induce muscle degeneration
37. Absence of α-syntrophin leads to structurally aberrant neuromuscular synapses deficient in utrophin
38. In vivo requirement of the α-syntrophin PDZ domain for the sarcolemmal localisation of nNOS and aquaporin-4
39. Interactions between beta 2-syntrophin and a family of microtubule-associated serine/threonine kinases
40. Stress-activated protein kinase-3 interacts with the PZ domain of α1-syntrophin
41. Expression profiling in the muscular dystrophies: Identification of novel aspects of molecular pathophysiology
42. 1 integrin associates with a dystrophin-containing lattice during muscle development
43. Bidirectional signaling between sarcoglycans and the integrin adhesion system in cultured L6 myoblasts
44. Dystrophic muscle in mice chimeric for expression of α5 integrin
45. Mutations in the integrin alpha 7 gene cause congenital myopathy
46. Absence of integrin alpha-7 causes a novel form of muscular dystrophy
47. Laminin polymerisation induces a receptor-cytoskeleton network
48. Distinct roles for dystroglycan, β1 integrin and perlecan in cell surface laminin organisation
49. The crystal structure of a laminin G-like module reveals the molecular basis of α-dystroglycan binding to laminin, perlecan and agrin
50. Structure of the C-terminal laminin G-like domain pair of the laminin α2 chain harbouring binding sites for α-dystroglycan and heparin
51. Molecular basis of muscular dystrophies
52. A missense mutation in the αB-crystallin chaperone gene causes a desmin-related myopathy
53. Missense mutations in desmin associated with familial cardiac and skeletal myopathy
54. A dysfunctional desmin mutation in a patient with severe generalized myopathy
55. Disruption of muscle architecture and myocardial degeneration in mice lacking desmin
56. Plectin deficiency results in muscular dystrophy with epidermolysis bullosa
57. Myotilin, a novel sarcomeric protein with two Ig-like domains, is encoded by a candidate gene for limb-girdle muscular dystrophy
58. Telethonin, a novel sarcomeric protein of heart and skeletal muscle
59. Myotilin is mutated in limb girdle muscular dystrophy 1A
60. Limb-girdle muscular dystrophy type 2G is caused by mutations in the gene encoding the sarcomeric protein telethonin
61. Filamin 2 (FLN2): A muscle-specific sarcoglycan interacting protein
62. Indications for a novel muscular dystrophy pathway: Filamin, the muscle-specific filamin isoform, interacts with myotilin
63. Identification of a new autosomal dominant limb-girdle muscular dystrophy locus on chromosome 7
64. Mutations in the proteolytic enzyme calpain cause limb-girdle muscular dystrophy-type 2A
65. Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy
66. Muscle-specific calpain, p94, responsible for limb girdle muscular dystrophy type 2A, associates with connectin through IS2, a p94-specific sequence
67. Increase in the level of m-calpain correlates with the elevated cleavage of filamin during myogenic differentiation of embryonic muscle cells
68. In vitro proteolysis of brain spectrin by calpain I inhibits association of spectrin with ankyrin-independent membrane binding site(s)
69. Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins
70. Transgenic overexpression of caveolin-3 in skeletal muscle fibers induces a Duchenne-like muscular dystrophy phenotype
71. Caveolin-3 directly interacts with the C-terminal tail of β-dystroglycan: Identification of a central WW-like domain within caveolin family members
72. The interaction of dystrophin with β-dystroglycan is regulated by tyrosine phosphorylation
73. The WW domain: Linking cell signalling to the membrane cytoskeleton
74. Tyrosine phosphorylation of β-dystroglycan at its WW domain binfing motif, PPxY, recruits SH2 domain containing proteins
75. Mutations in the laminin alpha 2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy
76. Identification of a novel X-linked gene responsible for Emery-Dreifuss muscular dystrophy
77. Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy
78. Genetic localisation of a newly recognised autosomal dominant limb-girdle muscular dystrophy with cardiac involvement (LGMD1B) to chromosome 1q11-12
79. A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B
80. Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy
81. Absence of gamma-sarcoglycan (35-dag) in autosomal recessive muscular-dystrophy linked to chromosome 13q12
82. Missense mutations in the adhalin gene linked to autosomal recessive muscular dystrophy
83. β-sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex
84. Autosomal recessive limb-girdle muscular dystrophy, LGMD2F, is caused by a mutation in the delta-sarcoglycan gene
85. The molecular basis of muscular dystrophy in the mdx mouse: A point mutation
86. Postsynaptic abnormalities at the neuromuscular junctions of utrophin-deficient mice
87. Subtle neuromuscular defects in utrophin-deficient mice
88. Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy
89. Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: A model for Duchenne muscular dystrophy
90. Murine muscular dystrophy caused by a mutation in the laminin α2 (Lama2) gene
91. Progressive muscular dystrophy in α-sarcoglycan-deficient mice
92. Loss of the sarcoglycan complex and sarcospan leads to muscular dystrophy in β-sarcoglycan-deficient mice
93. γ-sarcoglycan deficiency leads to muscle membrane defects and apoptosis independent of dystrophin
94. Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: A novel mechanism for cardiomyopathy and muscular dystrophy
95. Sarcospan-deficient mice maintain normal muscle function
96. An agrin minigene rescues dystrophic symptoms in a mouse model for congenital muscular dystrophy